Changes to OTC derivatives margining and what it means for the buy-side
GlobalCapital, is part of the Delinian Group, DELINIAN (GLOBALCAPITAL) LIMITED, 4 Bouverie Street, London, EC4Y 8AX, Registered in England & Wales, Company number 15236213
Copyright © DELINIAN (GLOBALCAPITAL) LIMITED and its affiliated companies 2024

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement
Sponsored Content

Changes to OTC derivatives margining and what it means for the buy-side

euroclear logo

As buyside firms look at their options for sourcing, mobilising and protecting collateral assets to be used as margin, whether for cleared or non-cleared OTC derivatives instruments, they very soon come up against problems of fragmentation.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request a Free Trial or Login
Gift this article